⌘K

Login Start Free

Home/Filings/4/0001127602-23-002682

4//SEC Filing

Eisele Jeffrey 4

Accession 0001127602-23-002682

CIK 0001492422other

View on SEC.gov Company Profile

Filed

Jan 29, 7:00 PM ET

Accepted

Jan 30, 4:58 PM ET

Size

4.4 KB

Accession

0001127602-23-002682

Insider Transaction Report

Form 4

Period: 2023-01-27

Apellis Pharmaceuticals, Inc.APLS

Chief Development Officer

Transactions

Tax Payment
Common Stock
2023-01-27$52.77/sh−367$19,367→ 47,351 total

Footnotes (1)

[F1]This represents shares withheld for tax on a restricted stock unit release.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Apellis Pharmaceuticals, Inc.

CIK 0001492422

Entity typeother

Related Parties

1

filerCIK 0001827326

Filing Metadata

Form type: 4
Filed: Jan 29, 7:00 PM ET
Accepted: Jan 30, 4:58 PM ET
Size: 4.4 KB

View on SEC.gov